CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
Moderna received three significant FDA approvals this year, including the next-generation COVID-19 vaccine mNEXSPIKE, mRESVIA ...
Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...
Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...
Moderna is backing the American Lung Association’s (ALA’s) call for people with lung diseases to get vaccinated for the ...
Moderna is asking U.S. regulators to allow for use of its COVID-19 vaccine on the nation's youngest children. Moderna submitted data to the Food and Drug Administration Thursday for emergency use ...
Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...
GlobalData on MSN
Moderna scraps mRNA vaccine in congenital CMV on Phase III failure
While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...
A key question for investors going forward will be whether Moderna's other latent virus vaccines for Epstein-Barr and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Shares of Moderna Inc. fell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback